Deborah J. Marriott
Department of Microbiology and Infectious Diseases
St. Vincent's Hospital
Deborah J. Marriott has not added Biography.
If you are Deborah J. Marriott and would like to personalize this page please email our Author Liaison for assistance.
Further evaluation of the MRSA-Screen kit for rapid detection of methicillin resistance.
Journal of clinical microbiology Nov, 1999 | Pubmed ID: 10610377
Veillonella parvula discitis and secondary bacteremia: a rare infection complicating endoscopy and colonoscopy?
Journal of clinical microbiology Feb, 2007 | Pubmed ID: 17108070
Determinants of mortality in non-neutropenic ICU patients with candidaemia.
Critical care (London, England) , 2009 | Pubmed ID: 19594912
Candida colonization as a risk marker for invasive candidiasis in mixed medical-surgical intensive care units: development and evaluation of a simple, standard protocol.
Journal of clinical microbiology Apr, 2015 | Pubmed ID: 25673797
Oral ribavirin for respiratory syncytial virus infection after lung transplantation: Efficacy and cost-efficiency.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation Jul, 2015 | Pubmed ID: 25753833
Posaconazole Therapeutic Drug Monitoring in a Regional Hospital Setting.
Therapeutic drug monitoring Dec, 2016 | Pubmed ID: 27548694
Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations.
International journal of antimicrobial agents Oct, 2016 | Pubmed ID: 27562696
Problematic Dichotomization of Risk for Intensive Care Unit (ICU)-Acquired Invasive Candidiasis: Results Using a Risk-Predictive Model to Categorize 3 Levels of Risk From a Multicenter Prospective Cohort of Australian ICU Patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Dec, 2016 | Pubmed ID: 27601224
Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Chayanika Biswas*,1,
Sharon C-A. Chen*,1,2,3,
Catriona Halliday1,2,
Elena Martinez1,
Rebecca J. Rockett1,
Qinning Wang1,
Verlaine J. Timms1,
Rajat Dhakal1,
Rosemarie Sadsad1,
Karina J. Kennedy4,
Geoffrey Playford4,5,
Deborah J. Marriott6,
Monica A. Slavin7,
Tania C. Sorrell1,3,
Vitali Sintchenko1,2,3
1Centre for Infectious Diseases and Microbiology-Public Health, Westmead Hospital,
2Centre for Infectious Diseases and Microbiology Laboratory Services, ICPMR,
3Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney,
4Department of Microbiology and Infectious Diseases, Canberra Hospital and Health Services, Australian National University Medical School,
5Infection Management Services, Australian National University Medical School,
6Department of Microbiology and Infectious Diseases, St. Vincent's Hospital,
7Department of Infectious Diseases, Peter MacCallum Cancer Centre
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved